Holen Sie sich die Stockscreener-App
21.60
0.76%
0.1626
Schlusskurs vom Vortag:
$21.44
Offen:
$20.9
24-Stunden-Volumen:
13,158
Relative Volume:
0.94
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.50%
1M Leistung:
-3.98%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$20.85
$21.63
1-Wochen-Bereich:
$20.85
$21.65
52-Wochen-Spanne:
$20.64
$26.42
Dana Unconstrained Equity Etf Stock (DUNK) Company Profile
Firmenname
Dana Unconstrained Equity Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare DUNK vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DUNK
Dana Unconstrained Equity Etf
|
21.60 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.68 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.83 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.91 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
275.56 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
603.22 | 124.43B | 0 | 0 | 0 | 0.00 |
Dana Unconstrained Equity Etf Aktie (DUNK) Neueste Nachrichten
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients - AOL.com
How well a cancer treatment works may depend on the time of day you get it - AOL.com
Soleus Adds a Significant Number of Celcuity Shares - AOL.com
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition - AOL.com
Gossamer Bio (NASDAQ:GOSS): The High-Stakes Gamble Drawing Big Bank Interest - AOL.com
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes - AOL.com
Warning: This Skyrocketing Stock Has a Hidden Risk - AOL.com
Lilly signs up to $1.93 billion deal with Repertoire for autoimmune therapies - AOL.com
CSL licenses Eli Lilly's clazakizumab to cut cardiac risk in end-stage kidney disease - AOL.com
Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery - AOL.com
1 Reason I'd Buy Eli Lilly Stock and Never Sell - AOL.com
Eli Lilly Shares Surge on Weight-Loss Drug Momentum. Is It Time to Buy the Stock? - AOL.com
Worst-Performing Stock ETFs - Morningstar
PINK’s 58% Gains Since 2021 Come From Picking Winners, Not Owning Everything - AOL.com
Amazon's Cloud Growth Tied To AI Advances, Analyst Says - Benzinga
3 Best ETFs to Invest In, According to AI Analyst, 12/11/2025 - TipRanks
Why Recursion Pharamaceuticals Topped the Market Today - AOL.com
Dana Investment Advisors, Inc.'s Dana Unconstrained Equity ETF(DUNK) Holding History - GuruFocus
This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy? - AOL.com
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock - AOL.com
Merck secures $700 million funding from Blackstone to develop cancer therapy - AOL.com
Will Tidal Trust I Dana Unconstrained stock benefit from mergers2025 Volatility Report & Expert Curated Trade Setups - newser.com
Eli Lilly Blows Away Q3 Earnings Expectations - AOL.com
ETFs with Netflix, Inc. ( NFLX ) Exposure - ETF Database
Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing - AOL.com
Tidal Trust I Dana Unconstraine (DUNK) Interactive Stock Chart - Yahoo
Tidal Trust I Dana Unconstrained Equity ETF (NYSE:DUNK) Stock Quote - FinancialContent
Eli Lilly: Beyond Weight Loss - AOL.com
DUNK Pivot Points, Technical Analysis and Moving AveragesTidal Trust IDana Unconstrained Equity Etf Technicals - CMLviz
DUNK | Dana Unconstrained Equity ETF Overview - MarketWatch
US ETF launches from 11th to 18th September, 2025 - ETF Express
Dana Investment Dives Into ETFs With Growth And Dividend Funds DUNK And DIVE - Benzinga
UniFirst Corporation Plans to Announce Fourth Quarter Results on October 22, 2025 - The Manila Times
Great-West Lifeco announces offering of Series Z Preferred Shares - The Manila Times
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split - The Manila Times
Dana Investment Advisors Launches Two New ETFs: Dana Unconstrained Equity ETF (DUNK) and Dana Concentrated Dividend ETF (DIVE) - The Manila Times
Investor Reports Highlight Lyno AI Presale Growth as Market Attention Builds - The Manila Times
XRP-Ripple Reports Spotlight MAGACOIN FINANCE After Crossing $14 Million in Presale Funding - The Manila Times
King Copper Discovery Corp. Announces Closing of $15 Million Financing - The Manila Times
Dana Unconstrained Equity ETF Holdings - Quiver Quantitative
Check out Dana Unconstrained Equity ETF's stock price (DUNK) in real time - CNBC
Is Eli Lilly Stock a Buy After Gaining 5% in 1 Day? - AOL.com
Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment - AOL.com
GeoWealth: What's New On The Model Marketplace - The Wealth Advisor
What is unconstrained equity investing? - blackrock.com
Top performing managers by category: separate accounts, 4th Quarter 2023 - Pensions & Investments
Zephyr Releases PSN Top Guns List for Q1 2023 Highlighting Best-In-Class Separate Accounts, Managed Accounts and Managed ETF Strategies - Stock Titan
Finanzdaten der Dana Unconstrained Equity Etf-Aktie (DUNK)
Es liegen keine Finanzdaten für Dana Unconstrained Equity Etf (DUNK) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):